Sort
21,453 grants matching “tuberculosis”
Understanding HIV's impact on RR/MDR-TB development and transmission through genomics
$186,325Tara Catherine Bouton · Boston Medical Center · K23 · FY2024 · AI
Localization and assembly of the M. tuberculosis ESX-1 secretory apparatus
$186,316Keith M Derbyshire · Wadsworth Center · R21 · FY2010 · AI
Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infection
$186,278Grace C John-Stewart · University Of Washington · R01 · FY2012 · HD
Novel gyrase inhibitors targeting Mycobacterium tuberculosis
$186,265Fenfei Leng · Florida International University · R21 · FY2024 · AI
Impact of a multimodal intervention to reduce dual stigma and improve treatment outcomes in HIV/Drug-resistant TB co-infected patients in KwaZulu-Natal, South Africa
$186,251Max O'Donnell · Columbia University Health Sciences · R21 · FY2019 · TW
Novel membrane remodeling systems in Actinobacteria and their role in antibiotic resistance
$186,250Herve Roy · University Of Central Florida · R21 · FY2020 · AI
Distinct responses of lung macrophages and airway epithelial cells to Hawai'i-derived volcanic ash and nontuberculous mycobacteria
$186,250Jennifer R. Honda · University Of Texas Hlth Ctr At Tyler · R21 · FY2024 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$186,235Laurie Gill · South Dakota State Dept Of Health · U52 · FY2006 · PS
Congugal DNA transfer into M. tuberculosis
$186,228Keith M Derbyshire · Wadsworth Center · R21 · FY2006 · AI
Elucidation of the molecular mechanism(s) for the non-responsiveness of CD38- AMs to tuberculosis infection
$186,195Davide Pisu · Texas A&M University Health Science Ctr · R21 · FY2024 · AI
Subcellular Mechanisms for Fungal Phagosome Maturation in Macrophages
$186,192Michael K Mansour · Massachusetts General Hospital · K08 · FY2015 · AI
Clinical and Economic Outcomes of HIV, Cigarette Smoking, and Smoking Cessation Interventions
$186,192Krishna P Reddy · Massachusetts General Hospital · K01 · FY2020 · DA
Subcellular Mechanisms for Fungal Phagosome Maturation in Macrophages
$186,192Michael K Mansour · Massachusetts General Hospital · K08 · FY2016 · AI
Exploiting Fungal Natural Products to Discover Novel Scaffolds That Inhibit Dormant and Drug-Resistant TB
$186,189Kyle H Rohde · University Of Central Florida · R21 · FY2018 · AI
The role of innate immunity in the acquisition of sterile protection against TB infection
$186,139Adriana Weinberg · University Of Colorado Denver · R21 · FY2018 · AI
Emory Specialized Center of Research Excellence (SCORE) on Sex Differences
$186,047Ighovwerha Ofotokun · Emory University · U54 · FY2025 · AG
Towards drugs that prevent resistance to the HIV OI, TB
$186,014David Alland · Univ Of Med/Dent Of Nj-Nj Medical School · R21 · FY2006 · AI
Examination of phage resistance and susceptibility in M tuberculosis
$185,968Jeffrey D. Cirillo · Texas A&M University Health Science Ctr · R21 · FY2025 · AI
Molecular mechanisms of the stringent response in Mycobacterium tuberculosis
$185,938Volker Briken · Univ Of Maryland, College Park · R21 · FY2018 · AI
POTENTIALLY BIOACTIVE METABOLITES FROM TROPICAL FUNGI
$185,933Anastacio Emiliano · University Of Puerto Rico · P20 · FY2010 · RR
Sequencing Core
$185,915Gregory Seumois · La Jolla Institute For Immunology · U19 · FY2025 · AI
Training of Ugandans in Basic Research on TB and Emerging Infectious Diseases
$185,878Jerrold J. Ellner · Boston Medical Center · D43 · FY2018 · TW
BCG efficacy against W-Beijing TB strains
$185,875Ian M Orme · Colorado State University · R21 · FY2014 · AI
Environmental mycobacteria and BCG interference
$185,875Ian M Orme · Colorado State University · R21 · FY2014 · AI
Minipigs as animal model for infant TB and vaccine efficacy
$185,875Mercedes Gonzalez-Juarrero · Colorado State University · R21 · FY2015 · AI